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ABSTRACT
Objective: This study evaluated the antioxidant and hepatoprotective activities of the dichloromethane (DCM-F) and n-butanol (BUT) fractions of 
Vitex doniana and identified the bioactive constituents using liquid chromatography-mass spectrometry (LC-MS) analysis.
Methods: The methanol extract of the leaves was subjected to liquid-liquid fractionation and the BUT soluble separated by vacuum LC (VLC) using 
binary mixtures of DCM in methanol (1 L) sequentially in the ratios of 9:1 BF1–1:9 BF5. The antioxidant activity was investigated in vitro using 1, 
1-diphenyl-2-picrylhydrazyl (DPPH) scavenging, phosphomolybdenum total antioxidant capacity, and ferric ion reducing antioxidant power assay 
methods. The in vivo antioxidant potential was performed by measuring the concentrations of both enzymatic and non-enzymatic parameters in 
carbon tetrachloride (CCl4)-induced hepatic injury.
Results: The extract, DCM-F, and the VLC sub-fractions showed good antioxidant activity which is comparable with ascorbic acid (53.6%). DCM-F 
showed the highest antioxidant activity (71.6%), while the least activity was shown by BF5 (15.0%). Peak dereplication of LC-MS chromatograms 
identified several putative compounds in the BUT soluble. DCM-F caused a significant increase (p<0.05) in superoxide dismutase, catalase, glutathione 
peroxidase, and Vitamins C and E in CCl4-induced rats compared to standard. The levels of serum alkaline phosphatase, alanine aminotransferase and 
aspartate aminotransferase, and malondialdehyde that were elevated in CCl4-induced rats were also significantly reduced (p<0.05) by the DCM-F 
compared to standard.
Conclusion: The ability of V. doniana leaves to mop up free radicals and reverse the CCl4-induced hepatic injury in rats suggests antioxidant potentials. 
The bioactive compounds identified in BUT fraction could support its ethnomedicinal uses in the treatment of illnesses associated with radical 
scavenging activity.
Keywords: Vitex doniana, Dereplication, Antioxidant, Phytochemical constituents, Liquid chromatography-mass spectrometry.
INTRODUCTION
Man has depended on plants and plant products for food and 
medicine [1]. The use of herbs to cure ailments in the olden days, 
even with little knowledge of their active principles, formed the 
backbone of current research in phytomedicine. All parts of medicinal 
plants are useful in the cure of disease and this forms the basis for 
the discovery of new drugs [2]. Their availability has caused an 
increased interest in their supplements and substance composition 
such as nutrients, mineral components, and bioactive compounds 
that are essential for drug discovery and development [3]. Plant 
products are known to be present in more than 50% of western 
drugs and have provided defense against pathogens or template for 
synthetic drugs [2].
Vitex doniana (Family Verbenaceae), commonly called black plum, is 
a Savanna plant species in wooded grasslands and can also be found 
along forest edges [4]. It is locally known in Nigeria as uchakiri (Igbo), 
tunci (Fulani), dinya (Hausa), and oori-nla (Yoruba) [5]. V. doniana 
possesses great potential in the management and prevention of a 
wide range of human diseases [6]. It is consumed in Nigeria as 
sauce and vegetables in meals [7]. In ethnomedicine, it is employed 
in the management of diarrhea, rheumatic and stomach pains, 
inflammatory disorders, and dysentery [8]. It also has antioxidant 
properties and anti-hyperlipidemic activities [4,6], all of which 
could be attributed to the phenolic and alkaloidal constituents of the 
extract. 
Therefore, it was imperative to identify potential bioactive fingerprints 
from V. doniana for eventual isolation, characterization, and for the 
evaluation of its antioxidant potential using in vitro and in vivo models.
METHODS
Plant material
The leaves were collected from farmland in Ibagwa, Enugu State, 
Nigeria and dried under shade. Identification was done by Prof. Charles 
N. Mba of the Department of Soil Science, School of Agriculture and 
Agricultural Technology of Federal University of Technology, Owerri. A 
voucher specimen (Number UUH 998) of the sample was subsequently 
deposited at the herbarium of the department.
Preparation of extract
The dried leaves were ground into a fine powder. A 250 g of powdered 
material was cold macerated in 1.5 L 95%v/v methanol for 48 h and 
filtered using Whatman filter paper #1 (Whatman Int. Ltd., Maidstone). 
The filtrate was concentrated to dryness in vacuum at room temperature.
Liquid-liquid fractionation
The dried extract was redissolved in aqueous methanol (10%v/v) and 
successively subjected to liquid-liquid fractionation, in equal volumes 
(500 ml) of n-hexane, dichloromethane (DCM), ethyl acetate, and n-butanol 
(BUT) in increasing order of polarity. The extracts were separated with 
separating funnel and the filtrates of respective fractionating solvent were 
concentrated using a rotary evaporator under reduced pressure.
© 2020 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2020.v13i8.37956
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Vacuum liquid chromatography (VLC) separation of extract
VLC technique was adopted to further separate the BUT soluble. A 2 g 
portion was dissolved in 5 ml methanol and introduced to the silica gel 
(G100-200 mesh size) slurry packed 40 × 3 cm column (sample to silica 
gel ratio 1:40) at room temperature. The applied fraction was eluted 
with a gradient of mobile phase consisting of DCM in methanol (1 L), 
each starting with 90 % DCM and gradually increasing the amount 
of methanol to 30, 50, 70, and 90% to obtain VLC fractions BF1-BF5, 
respectively.
Qualitative phytochemical analysis
Freshly prepared extract and the BUT fractions were subjected to 
qualitative phytochemical analysis to ascertain their constituents using 
standard procedures [9,10].
Determination of antioxidant property
1, 1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging assay
The scavenging activity of extract, fractions, and VLC sub-fractions on 
DPPH was measured colorimetrically at 517 nm using ascorbic acid as 
standard [11]. The sample was dissolved in methanol to make a 1000 ppm 
stock. A 5 ml of DPPH solution was put into a test tube containing 1 ml of 
each concentration and the solution was evenly mixed. The mixture was 
incubated for 3 min and observed for color change (deep violet to yellow). 
The absorbance was measured at 517 nm for the extract and fractions. 
The concentration of the extract and ascorbic acid used was 10, 20, 30, 
40, and 50 ppm. The free radical scavenging activity was obtained from:
% inhibition = [(A0 – A1)/A0] × 100; where A0 = absorbance of blank 
and A1 = absorbance of test sample
Phosphomolybdenum total antioxidant capacity (TAC) assay
Phosphomolybdenum reagent was prepared by reacting 100 ml each 
of 0.6 M H2SO4, 28 mM disodium phosphate and 4 mM ammonium 
molybdate. A 3 ml of the reagent was added to 1 ml each of the different 
concentrations of the extract and fractions in methanol. The mixture was 
incubated at 95°C for 90 min and allowed to cool at room temperature 
for 15 min. The absorbance was determined at 695 nm. A blank was 
made by adding methanol to the reagent solution (1:3) and subjected to 
similar treatments as the test samples. Five different concentrations of 
the standard ascorbic acid were prepared and used for calibration. The 
concentrations of the extract, fractions, and ascorbic acid used were 
100–6.25 μg/ml. The TAC of the samples was measured as the number 
of ascorbic acid per gram of the sample [11,12].
Ferric ion reducing antioxidant power (FRAP) assay
Different concentrations (100–6.25 μg/ml) of the extract and fractions 
were added to 2.5 ml of 20 mM phosphate buffer and 2.5 ml %w/v 
potassium ferricyanide. The mixture was incubated at 50% for 30 min. 
Then, 2.5 ml of 10% w/v trichloroacetic acid and 0.5 ml 0.1% w/v ferric 
chloride were added to the mixture. This was kept aside for 10 min and 
absorbance determined at 700 nm using ascorbic acid as standard [11].
UHPLC-MS analysis
The BUT soluble was dissolved in 80%v/v aqueous methanol at a 
5 mg/ml concentration and analyzed with UHPLC/ESI-QTOF MS/MS [13]. 
Chromatographic separations were performed on a Dionex Ultimate 3000 
RS Liquid Chromatography System with Dionex Acclaim RSLC 120, C18 
column (2.1×100 mm, 2.2 μm) using binary gradient (A: Water with 0.1% 
v/v formic acid; B: Acetonitrile with 0.1% v/v formic acid) at 0.8 ml/min: 
0 to 9.5 min: Linear from 5% B to 100% B; 9.5–12.5 min: Isocratic 100% 
B; 12.5–12.6 min: Linear from 100% B to 5% B; 12.6–15 min: Isocratic 5% 
B. The injection volume was 5 μl. Eluted compounds were detected over 
a wavelength range of 200–400 nm and a Bruker Daltonics micrOTOF-QII 
quadrupole/time-of-flight mass spectrometer. UPLC-MS chromatograms 
and mass spectra were calibrated with Bruker Daltonics Profile, Analysis 
2.0 (Bruker Daltonik GmbH, Germany, 2010. Peak alignment (Join aligner) 
was used to match relevant peaks across multiple samples under m/z and 
retention time (tR) tolerances to generate a list of peaks and their partial 
identification was performed by querying automatically the exact masses 
of molecular ions [M+H]+ and common adducts ([M+Na]+, [M+NH4]+, 
[M+K]+) (error = 0.005 Dalton). The molecular formulae of possible 
compound(s) from each de-convoluted peaks with their corresponding tR 
are shown in Table 1.
Identification of constituents
Interpretation of data was based upon the database of the National 
Institute Standard and Technology and the dictionary of natural 
products (https://www.dnp.chemnetbase.com/). The spectra of 
unknown compounds and that of the known compounds in the 
repositories were compared. The tR, molecular weight, and molecular 
formula of the sample material were obtained.
Animal studies
Acute toxicity test
Samples of extract and fractions of the plants were made in 3% aqueous 
tween 80. Sixty mice of either sex weighing 24.6±7.6 g were used in 
the study. Three groups of mice containing five mice each were given 
10, 100, and 1000 mg/kg, respectively, of the methanol extract and 
DCM fractions intraperitoneally (i.p). They were observed closely 
for 24 h for acute toxicity signs and behavioral responses. Further 
elevated doses of 1900, 2600, and 5000 mg/kg were given i.p to five 
other mice, respectively, based on the previous observation. They were 
observed individually for 1 h after the last dosing and once daily for 
14 days, for acute toxicity signs and behavioral changes. The maximum 
test dose of 5000 mg/kg was used as stipulated in organization for 
economic cooperation development guidelines. Median lethal dose was 
determined as the geometric mean of the maximum dose of the extract/
fraction that resulted in 0 lethality and the maximum dose that resulted 
in 100% death [14].
Animals
Six groups (A-F) of male albino rats weighing 163.6±2.8 g were housed 
in cages of five rats each. They were kept to acclimatize for 10 days and 
were allowed free access to food and water. Liver damage in animals was 
Table 1: Constituents of the n-butanol sub-fractions of V. doniana leaves
Fraction Mass tR (min) Intensity Adduct Fig. 4 Formula Class
BF2 441.3 6.4 5.00×103 [M+K]+ 9 C27H44O7 Lipid
BF2 361.3 8.9 0.75×104 [M+H]+ 10 C22H34O4 Diterpene
BF2 373.3 8.9 0.60×104 [M+H]+ 6 C19H18O8 Flavonoid
BF2 373.3 8.9 0.60×104 [M+H]+ 8 C19H18O8 Flavonoid
BF2 304.3 9.4 2.90×104 [M+NH4]+ 1 C19H30O4 Lignan
BF2 333.3 10.3 6.50×104 [M+H]+ 7 C18H38NO4 Alkaloid
BF2 301.1 10.5 1.05×105 [M+H]+ 2 C15H10O8 Flavonoid
BF2 376.3 11.2 0.70×104 [M+2H]+ 11 C22H34O5 Diterpene
BF2 338.3 13.8 2.80×104 [M+NH4]+ 3 C20H20O6 Lignan
BF3 457.4 8.9 3.25×104 [M+H]+ 5 C30H48O3 Triterpene
BF3 317.1 10.5 0.10×105 [M+H]+ 4 C15H10O8 Flavonoid
BF3 374.3 11.5 1.50×104 [M+2H]+ 12 C16H24O10 Monoterpene iridoid
V. doniana: Vitex doniana
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induced with carbon tetrachloride (CCl4) in paraffin oil (1:1) on the 1st 
and 8th days. Permission to use animals for this study was obtained from 
the University of Nigeria Ethics Committee guidelines on the handling of 
laboratory animals in accordance with “Principles of Laboratory Animal 
Care” (NIH publication no. 85-23, revised 1985) and/or the declaration 
of Helsinki promulgated in 1964 as amended in 1996
Treatments
Rats in Group A (normal control) were given distilled water (0.5 ml) 
orally once daily. Group B (untreated) received CCl4 solution (0.5 ml). 
Group C (standard control) animals were given CCl4 (0.5 ml) and 200 
mg/kg bodyweight of butylated hydroxytoluene (BHT) simultaneously. 
Groups D, E, and F received simultaneously 0.5 ml of CCl4 each and 200, 
400, and 600 mg/kg of fractions, respectively. Treatments with doses of 
extract, fractions, and the standard lasted for 14 days [15].
Serum and tissue preparation
The rats were sacrificed under CCl4 anesthesia, 24 h after the last 
daily doses, and were made to bleed through the ocular puncture 
into centrifuge tubes. The sera were obtained by allowing the blood 
sample to clot for 15 min and centrifuging at 3500 rpm at 40°C × 10 
min. Biochemical assay was carried out within 12 h of preparation of 
sera. Liver removed from the rat was cut thinly and then homogenized 
in ice-cold 1.25 M sucrose solution (1:5 w/v). Centrifugation of the 
homogenate was done at 3500 rpm × 10 min at 40°C to obtain the 
supernatant which was preserved at −20°C for various biochemical 
assays [15].
Assay of biochemical parameters
The alkaline phosphatase (ALP), alanine aminotransferase (ALT), and 
aspartate aminotransferase (AST) were determined as outlined in the 
Randox kit while total and conjugated bilirubin were assayed following 
previously described protocols [16]. Other parameters such as superoxide 
dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) [17,18], 
Vitamin C [19], Vitamin E [20], and lipid peroxidation (malondialdehyde 
[MDA]) were determined by standard method [17, 21].
Statistical analysis
Statistical analyses were carried out with SPSS version 16.0 windows. 
All the values were expressed as mean±standard deviation and analyzed 
for analysis of variance and post-hoc Duncan multiple range tests. The 
difference between groups was considered significant at p<0.05 levels [22].
RESULTS
Result of phytochemical test
The methanol extract, DCM, and BUT fractions and the VLC sub-
fractions all tested positive for the presence alkaloids, saponins, 
tannins, terpenoids, flavonoids, lignans, and iridoid glycoside.
Results of antioxidant test
The methanol extract, DCM, and BUT fractions and the VLC sub-fractions 
tested positive to qualitative antioxidant assay test (i.e., color changed 
from violet to yellow). The scavenging activity of extract and fractions on 
DPPH free radicals was expressed as percentage inhibition, and they were 
compared with standard ascorbic acid (Fig. 1). The DCM-fraction (DCM-F) 
produced significant inhibition (71.6%) with an IC50 of 26.3 mg/g, higher 
than that of ascorbic acid (53.6%) with an IC50 of 20.6 mg/kg. In the 
phosphomolybdenum TAC and FRAP assays, the reducing potency of 
the extract and fractions was significant compared with that of ascorbic 
acid. The DCM-F showed higher reducing potency (1.500±0.004) when 
compared with the standard (0.30±0.00) (Fig. 2) in the TAC model. 
Similarly, in the FRAP model, the reducing effect of DCM-F is 1.51±0.001 
compared to 0.27±0.002 recorded with the standard. This indicates that 
DCM-F has greater reduction potency than the standard (Fig. 3).
Result of UHPLC-MS analysis
The LC-MS analysis, including their molecular formula, molecular 
weight, tR, peak area, and composition of the bioactive components 
Fig. 2: Phosphomolybdenum total antioxidant capacity assay of 
Vitex doniana. (ME= methanol extract; DCM-F= dichloromethane 
fraction; BF1-5= n-butanol fractions 1–5)
Fig. 1: 1, 1-diphenyl-2-picrylhydrazyl scavenging activity of the 
extract and fractions of Vitex doniana leaves. (ME= methanol 
extract; DCM-F= dichloromethane fraction; BF1-5= n-butanol 
fractions 1–5)
Fig. 3: Reducing effects of Vitex doniana leaves. (ME= methanol 
extract; DCM-F= dichloromethane fraction; BF1-5= n-butanol 
fractions 1–5)
of V. doniana leaves, is presented in Table 1 and Fig. 4. The base peak 
chromatograms of the active sub-factions and mass spectra of the 
identified constituents are shown in Figs. 5 and 6, respectively.
Many significant physiological active components were identified from 
the fractions by LC-MS analysis (Fig. 4) such as vitedoin B (1), quercetin 
(2), vitedoin A (3), myricetin (4), betulinic acid (5), casticin/vitexicarpin 
(6), vitexlactam (7), 5,3-dihydroxy-3,6,7,4-tetramethoxylflavone 
(8), 20-hydroxyecdysone (9), rotundifuran (10), vitexilactone (11), and 
mussaenosidic acid (12).
Result of acute toxicity studies
Acute toxicity studies showed that both the extract and fractions did 
not produce lethality (mortality) in the treated mice during the period 
of the study. There was no significant weight loss and changes in 
feeding patterns in the mice during the study period. The mice did not 
experience skin dryness, hair loss, and general weakness during the 
study period.
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Results of in vivo study
Treatment with CCl4 increased significantly (p<0.05), the levels of ALP, 
ALT, and AST in the serum (Table 2). Co-administration of CCl4 and 
doses of V. doniana resulted in a corresponding decrease of the serum 
enzymes. There was no significant difference in serum enzyme levels 
in CCl4 and 600 mg/kg of the fraction, as shown in 80.4%, 84.3%, and 
82.8% reduction, respectively.
The significant reduction (p<0.05) in total and conjugated bilirubin 
levels following CCl4-induced hepatotoxicity was reversed following 
treatments (Table 2). At 600 mg/kg, total and conjugated bilirubin 
was increased by 45% and 94.5%, respectively. Similarly, there was a 
significant (p<0.05) reversal of the reduction in the SOD, GPx, and CAT 
observed among the CCl4-induced animals.
The effect of V. doniana on non-enzymatic antioxidant parameters of 
CCl4-induced hepatotoxic rats is shown in Fig. 7. A 600 mg/kg of the 
fraction significantly increased Vitamins C and E serum levels by 
33.19% and 58.45%, respectively. This compared well (p<0.05) with 
that of the distilled water control group.
The effect of V. doniana on peroxidized MDA in rats is shown in Fig. 8. 
BHT reduced MDA significantly (p<0.05) by 51.2% lower than 57.35% 
reduction caused by a 600 mg/kg of the fraction.
DISCUSSION
Antioxidants prevent, protect, and repair free-radical mediated 
damage [23]. The DCM fraction of V. doniana leaves showed 
antioxidant activity in this study higher than its BUT fraction when 
Table 2: Effect of V. doniana on serum biochemical markers and antioxidant enzymes of CCl4-induced hepatotoxic rats
Treatment 
group




SOD (iu/mg) CAT (iu/mg) GPx (iu/mg)
A 75.96±3.45a 10.78±0.19a 11.68±0.43a 0.38±0.02a 34.42±1.14a 11.43±0.04a 1.17±0.08a 11.14±0.75a
B 92.61±9.50b 12.90±0.25b 14.36±0.34b 0.18±0.01b 32.54±0.35b 10.92±0.04b 1.12±0.08a 9.80±0.15b
C 76.02±4.36a 10.74±0.10a 11.76±0.27a 0.39±0.02a 35.55±0.24c 11.43±0.01a 1.27±0.01b 11.22±0.01a
D 56.78±2.60b 10.22±0.08b 11.32±0.33a 0.33±0.07c 34.61±0.23a 11.35±0.01b 1.18±0.04a 10.77±0.44a
E 64.34±2.94c 10.37±0.05b 11.49±0.36a 0.37±0.04a 35.11±0.15a 11.40±0.01a 1.28±0.01c 10.71±0.47a
F 74.49±2.36a 10.88±0.04a 11.90±0.51a 0.40±0.01a 34.42±1.17d 11.45±0.01a 1.40±0.04d 11.22±0.01a
Values are means±SD of five replicates. a-dValues for the treatment groups (for each enzyme) with different superscripts with that of the distilled water control group are 
significant at p<0.05; BILI (T)= total bilirubin; BILI (D) =conjugated bilirubin. CCl4: carbon tetrachloride, SOD: Superoxide dismutase, CAT: Catalase, GPx: Glutathione 
peroxidase, ALP: Alkaline phosphatase, ALT: Alanine aminotransferase, AST: Aspartate aminotransferase, V. doniana: Vitex doniana, SD: Standard deviation
Fig. 4: Structures of some dereplicated compounds in BF2 and BF3
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compared with ascorbic acid as well as both the aqueous and 
ethanol extracts of V. doniana leaves as reported by Agbafor and 
Nwachukwu [6] suggesting the possibility of synergism in antioxidant 
property of constituents of extract. The scavenging effect of the 
extracts and fractions of V. doniana leaves on DPPH, together with 
their reducing effect on the ferric ion and phosphate-Mo(IV), may 
be related to lipid peroxidation, which works mainly in terminating 
free radical chain reaction. Its DCM fraction displayed the most 
outstanding scavenging activity more effective than the ascorbic acid, 
the reference standard used in this assay.
The dereplication analysis indicated that BUT fractions of V. doniana 
leaves contained numerous phytoconstituents such as alkaloids (7), 
flavonoids (4), lignans (2), terpenoid (4), and lipid (1) (Table 1). 
Importantly, 12 compounds were identified in the most active fractions; 
10 were identified in the BF2 and 2 in BF3. Compounds having antioxidant, 
analgesic, anticancer, anti-inflammatory, antibacterial, antiretroviral, and 
antimalarial activities were identified. Antioxidants identified included 
1, 2, 3, and 4, while anti-inflammatory agents identified are 5 and 6. 
Sheneni et al. [4] had earlier reported the use of V. doniana leaves as a 
diuretic, in the control of high blood pressure and in the treatment of 
swelling, edema, diabetes, and ulcer. The decoction has also been reported 
useful during labor to quicken delivery time. These might be due to the 
presence of antioxidant and anti-inflammatory constituents identified. 
Furthermore, Agbafor and Nwachukwu [6] reported the antioxidant 
properties of the leaves, root, and stem bark of V. doniana. These claims 
may be due to the presence of an antibacterial compound, 7 identified in 
BF2 sub-fraction and/or strong antioxidant compounds such as 2, 3, and 
4. Other identified phenolic compounds, 2, 4, 6, and 8 possess significant 
anticancer, anti-inflammatory, and antioxidant properties. Bioactive 
alkaloid such as 7 was also identified in both BF2 and BF3, and several 
alkaloids are known for their use in the cure and treatment of illness such 
as diarrhea and dysentery [3]. The BUT fraction quantification was found 
to be rich in phenolic compounds (flavonoids) and therefore exhibited 
good scavenging activity against DPPH.
Fig. 6: Compound spectra of some identified constituents of BF2 and BF3
Fig. 5: BPC of BF2 (upper) and BF3 (lower panel), mass 100-1000 Daltons
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The acute toxicity test performed on both the crude methanol extracts 
and the DCM fractions of V. doniana leaves showed that no death was 
recorded in the mice following oral administration of both methanol 
extracts and the DCM fractions. This signifies that both the methanol 
extracts and DCM fractions of both plants are relatively safe. This may 
be in agreement to the work of Sha’a et al. [14], which evaluated the 
toxicity of the extracts of V. doniana.
The animal study was designed on the rat model to assess the 
curative effects of V. doniana against the CCl4-induced toxicity in rats. 
CCl4 significantly elevated lipid oxidation and affects different blood 
biochemical parameters such as antioxidant markers and liver enzymes. 
Treatment with V. doniana prevented these effects, indicating that 
they can reverse the effects caused by CCl4. The ability of 600 mg/kg 
DCM fraction to reverse the damage caused by CCl4 administration in a 
way similar to BHT indicates the antioxidant potential of the fraction. 
V. doniana can prevent the buildup of free radicals in the animals. The 
ability of the DCM fraction to significantly lower the levels of ALP, ALT, 
and AST after CCl4 intoxication suggests the hepatocurative ability of 
the fraction. Yakubu et al. [7] in their previous work had reported the 
ameliorating effect of the extracts of V. doniana on the biochemical 
markers following an aluminum-induced injury on the liver.
When there is an obstruction in the excretion of bile due to liver injury, 
level of serum bilirubin increases [24], the 600 mg/kg fraction was 
able to normalize this trend following CCl4 toxicity, indicating it might 
Fig. 8: Effect of V. doniana on lipid peroxidized product 
(malondialdehyde) of rat liver. (Data are mean±standard 
deviation n=5. a-dSuperscripts with that of the distilled water 
control group are significant at p<0.05)
Fig. 7: Effect of Vitex doniana on some non-enzymatic antioxidants 
of rat. (Data are mean±standard deviation n=5. a-dSuperscripts 
with that of the distilled water control group are significant at 
p<0.05)
regenerate hepatocytes and healing of hepatic parenchyma. This is in 
agreement with the earlier work reported [7]. Liver toxicity also leads 
to failure or inefficiency of internal enzymatic mechanisms of SOD, CAT, 
and GPx. The DCM fraction can complement their in vivo free radical 
scavenging activity when taken. This is in agreement with the report 
of Chinwe [3] suggesting that leaves, root, and stem bark extracts of 
V. doniana showed antioxidant properties comparable to the standard 
antioxidant drugs. Similarly, the ability of the DCM fraction to reverse 
the depletion of Vitamins C and E caused by the toxicity of CCl4 
indicates that it can play an important role in protecting the natural 
defense system of the animals. A 600 mg/kg of DCM fraction was able 
to preserve the non-enzymatic antioxidant system. MDA in the liver of 
animals serves as an indicator of lipid peroxidation [25]. The inhibition 
of elevation of the level of MDA upon CCl4 administration also suggested 
the protective effect of the fractions against hepatic lipid oxidation 
induced by CCl4.
CONCLUSION
The study revealed the presence of potential bioactive compounds 
from V. doniana leaves. The DCM-F can prevent damage caused by free 
radicals, improve serum biochemical markers, repair hepatic enzymes 
and fibrosis, and regulate hepatocyte function. In summary, V. doniana 
could be a natural source of antioxidant molecules. At present, isolation 
of the bioactive compounds for the development of new agents of 
biomedical importance is ongoing.
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